Santi Nolasco

1.2k total citations
32 papers, 554 citations indexed

About

Santi Nolasco is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Santi Nolasco has authored 32 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 24 papers in Physiology and 7 papers in Surgery. Recurrent topics in Santi Nolasco's work include Asthma and respiratory diseases (24 papers), Respiratory and Cough-Related Research (16 papers) and Eosinophilic Esophagitis (7 papers). Santi Nolasco is often cited by papers focused on Asthma and respiratory diseases (24 papers), Respiratory and Cough-Related Research (16 papers) and Eosinophilic Esophagitis (7 papers). Santi Nolasco collaborates with scholars based in Italy, Canada and France. Santi Nolasco's co-authors include Claudia Crimi, Raffaele Campisi, Nunzio Crimi, Corrado Pelaia, Giulia Scioscia, Giuseppe Valenti, Girolamo Pelaia, Nicola Scichilone, Giovanna Elisiana Carpagnano and Enrico Heffler and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Santi Nolasco

30 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Santi Nolasco Italy 16 411 382 136 82 75 32 554
Mark Forshag United States 12 454 1.1× 411 1.1× 79 0.6× 125 1.5× 67 0.9× 16 604
Frank Trudo United States 16 938 2.3× 819 2.1× 183 1.3× 147 1.8× 108 1.4× 50 1.1k
Takuyo Chiba Japan 7 126 0.3× 262 0.7× 44 0.3× 88 1.1× 59 0.8× 24 502
Paul Paddle Australia 13 223 0.5× 252 0.7× 5 0.0× 106 1.3× 13 0.2× 37 432
Madan Roy Canada 6 200 0.5× 174 0.5× 28 0.2× 28 0.3× 47 0.6× 14 369
B Johansen Norway 10 82 0.2× 157 0.4× 14 0.1× 94 1.1× 18 0.2× 24 352
Aaron Kessel United States 6 50 0.1× 97 0.3× 17 0.1× 175 2.1× 15 0.2× 15 314
Steve Sharp United Kingdom 8 55 0.1× 31 0.1× 91 0.7× 72 0.9× 27 0.4× 9 436
Esam H. Alhamad Saudi Arabia 15 313 0.8× 580 1.5× 1 0.0× 52 0.6× 17 0.2× 47 648
Nils Kossack Germany 11 32 0.1× 110 0.3× 13 0.1× 30 0.4× 6 0.1× 43 316

Countries citing papers authored by Santi Nolasco

Since Specialization
Citations

This map shows the geographic impact of Santi Nolasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santi Nolasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santi Nolasco more than expected).

Fields of papers citing papers by Santi Nolasco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Santi Nolasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santi Nolasco. The network helps show where Santi Nolasco may publish in the future.

Co-authorship network of co-authors of Santi Nolasco

This figure shows the co-authorship network connecting the top 25 collaborators of Santi Nolasco. A scholar is included among the top collaborators of Santi Nolasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Santi Nolasco. Santi Nolasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nolasco, Santi, et al.. (2025). Achieving remission in severe asthma. PubMed. 3(2). 77–87. 3 indexed citations
3.
4.
Carpagnano, Giovanna Elisiana, Andrea Portacci, Santi Nolasco, et al.. (2024). Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission. Frontiers in Immunology. 15. 1343362–1343362. 18 indexed citations
5.
Scioscia, Giulia, Santi Nolasco, Raffaele Campisi, et al.. (2023). Switching Biological Therapies in Severe Asthma. International Journal of Molecular Sciences. 24(11). 9563–9563. 21 indexed citations
6.
Campisi, Raffaele, Santi Nolasco, Corrado Pelaia, et al.. (2023). Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study. Journal of Clinical Medicine. 12(12). 3953–3953. 19 indexed citations
7.
Portacci, Andrea, Raffaele Campisi, Enrico Buonamico, et al.. (2023). Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis. ERJ Open Research. 9(5). 419–2023. 11 indexed citations
8.
Scioscia, Giulia, Pasquale Tondo, Santi Nolasco, et al.. (2023). Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience. Journal of Clinical Medicine. 12(13). 4362–4362. 4 indexed citations
9.
Valentin, Simon, Daniel López‐Padilla, Santi Nolasco, et al.. (2023). ERS International Congress 2022: highlights from the Respiratory Intensive Care Assembly. ERJ Open Research. 9(3). 532–2022. 1 indexed citations
10.
Nolasco, Santi, Andrea Portacci, Raffaele Campisi, et al.. (2023). Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study. Frontiers in Immunology. 14. 1204444–1204444. 24 indexed citations
11.
Crimi, Claudia, Santi Nolasco, Raffaele Campisi, et al.. (2022). Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study. Journal of Clinical Medicine. 11(24). 7323–7323. 14 indexed citations
12.
Nolasco, Santi, et al.. (2022). Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report. Monaldi Archives for Chest Disease. 93(2). 4 indexed citations
13.
14.
Nolasco, Santi, Corrado Pelaia, Giulia Scioscia, Raffaele Campisi, & Claudia Crimi. (2022). Tezepelumab for asthma. Drugs of today. 58(12). 591–603. 9 indexed citations
15.
Pelaia, Corrado, Claudia Crimi, Santi Nolasco, et al.. (2021). Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy. Biomedicines. 9(12). 1822–1822. 20 indexed citations
16.
Campisi, Raffaele, Claudia Crimi, Santi Nolasco, et al.. (2021). Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program. Journal of Asthma and Allergy. Volume 14. 575–583. 47 indexed citations
17.
Nolasco, Santi, Claudia Crimi, Corrado Pelaia, et al.. (2021). Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study. The Journal of Allergy and Clinical Immunology In Practice. 9(12). 4371–4380.e4. 49 indexed citations
18.
Crimi, Claudia, et al.. (2021). Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study. Respiratory Medicine. 185. 106491–106491. 38 indexed citations
19.
Crimi, Claudia, et al.. (2020). Comparability of asthma control test scores between self and physician-administered test. Respiratory Medicine. 170. 106015–106015. 21 indexed citations
20.
Corrie, Pippa, A.M. Moody, Santi Nolasco, et al.. (2013). Is community treatment best? a randomised trial comparing delivery of cancer treatment in the hospital, home and GP surgery. British Journal of Cancer. 109(6). 1549–1555. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Forshag Breakdown of academic impact, for papers by Frank Trudo Breakdown of academic impact, for papers by Takuyo Chiba Breakdown of academic impact, for papers by Paul Paddle Breakdown of academic impact, for papers by Madan Roy Breakdown of academic impact, for papers by B Johansen Breakdown of academic impact, for papers by Aaron Kessel Breakdown of academic impact, for papers by Steve Sharp Breakdown of academic impact, for papers by Esam H. Alhamad Breakdown of academic impact, for papers by Nils Kossack
Rankless by CCL
2026